Neurovascular Mechanisms in Female Sexual Arousal Disorders and Potential Targets in Women: Is There a Role for Topical or Oral PDE-5 Inhibition in Treating Female Sexual Dysfunction (FSD)?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Neurovascular Mechanisms in Female Sexual Arousal Disorders and Potential Targets in Women: Is There a Role for Topical or Oral PDE-5 Inhibition in Treating Female Sexual Dysfunction (FSD)?

By "Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023. FEATURING Noel Kim

99 views

July 11, 2023

Speaker Name and Title: Noel Kim, PhD
The Princeton 4 meeting was sponsored by an ...
read more ↘ unrestricted grant from Sanofi.
Sanofi was not involved in choosing the content or speakers for the meeting.

Affiliation of the speaker:
Institute for Sexual Medicine
San Diego, California

Title of the speaker’s talk: “Neurovascular mechanisms in female sexual arousal disorders and potential targets in women. (Is there a role for topical or oral PDE-5 inhibition in treating female sexual dysfunction (FSD)? “

Financial disclosure/Conflict of Interest:
Consultant:
Prometheus Laboratories, Inc.
TriangleRX Consult, LLC
Softwave TRT, LLC
Sprout Pharmaceuticals, Inc.
↖ read less

Comments 0